This article was written by Follow Alberto holds a Master’s degree in Business Economics. During his academic career he acquired an extensive managerial and...
This article was written by Follow As a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading,...
This article was written by Follow Full time trader and investor. Instead of lengthy and boring articles, I prefer writing concise arguments about value...
By Frederick Fromm, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group While caution in some areas of the commodities space may be prudent, there...
ImmunoGen (NASDAQ:IMGN) is a large biopharmaceutical company (market cap of $4.8 billion) that uses antibody-drug conjugate (‘ADC’) technology to develop novel therapeutics against cancer....
Repligen (NASDAQ:RGEN) offers a comprehensive suite of products, including filtration, chromatography, process analytics, and proteins, catering to both upstream and downstream processes in the...
Living with memory loss and other cognitive limitations is hard. But when you can’t remember or can’t process information well enough to make important...
Investment thesis Synaptics (NASDAQ:SYNA) is experiencing severe headwinds due to the challenging environment with weak end markets’ spending. On the other hand, secular trends...